Published in
Elsevier, Vaccine, 12(31), p. 1569-1575, 2013
DOI: 10.1016/j.vaccine.2013.01.021
Links
Tools
A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults
Journal article published in 2013 by
Helen S. Marshall 
,
Peter C. Richmond ,
Michael D. Nissen ,
Ann Wouters,
James Baber,
Qin Jiang,
Annaliesa S. Anderson,
Thomas R. Jones,
Shannon L. Harris,
Kathrin U. Jansen,
John L. Perez
,
Peter C. Richmond ,
Michael D. Nissen ,
Ann Wouters,
James Baber,
Qin Jiang,
Annaliesa S. Anderson,
Thomas R. Jones,
Shannon L. Harris,
Kathrin U. Jansen,
John L. Perez
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 